SCHEMBL3017294

SCHEMBL3017294

O=S(=O)(c1ccc(OC(F)(F)F)cc1)C1CCN(c2nc(Cc3ccc(Cl)c(Cl)c3)cs2)CC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK1D P48730 1/20 0.36
LIPE Q05469 2/20 0.35
RPA1 P27694 1/20 0.35
AVPR1B P47901 1/20 0.35
TRPV1 Q8NER1 2/20 0.35
HDAC3 O15379 1/20 0.35
HDAC4 P56524 1/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC7 Q8WUI4 1/20 0.35
HDAC2 Q92769 1/20 0.35
HDAC10 Q969S8 1/20 0.35
HDAC11 Q96DB2 1/20 0.35
HDAC8 Q9BY41 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35
HDAC9 Q9UKV0 1/20 0.35
HDAC5 Q9UQL6 1/20 0.35
LMNA P02545 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
TRPM8 Q7Z2W7 3/20 0.34
MMP2 P08253 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3003366 0.93 DRD2 (0.36) LIPEAVPR1BTRPV1HDAC3HDAC4
SCHEMBL3023492 0.93 LIPE (0.36) LIPEAVPR1BHDAC3HDAC4HDAC1
SCHEMBL3015610 0.91 PSEN1 (0.38) LIPEAVPR1BHDAC3HDAC4HDAC1
SCHEMBL3015985 0.91 LIPE (0.37) LIPEAVPR1BHDAC3HDAC4HDAC1
SCHEMBL3006121 0.89 LIPE (0.36) LIPEAVPR1BHDAC3HDAC4HDAC1
SCHEMBL3011689 0.88 LIPE (0.37) LIPEAVPR1BTRPM8MMP2MMP9
SCHEMBL3000034 0.88 AVPR1B (0.42) LIPEAVPR1BHDAC3HDAC4HDAC1
SCHEMBL3014815 0.88 L3MBTL1 (0.41) LMNAL3MBTL1CTSSAREPHX2
SCHEMBL3017923 0.88 MAPT (0.40) LMNAL3MBTL1AREPHX2
SCHEMBL3013801 0.87 L3MBTL1 (0.39) TRPV1LMNAL3MBTL1AR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8722681-B2 N-sulfonyl thiazolylpiperazine derivatives and related N-sulfonyl heterocyclic derivatives for the treatment of neuro degenerative diseases NV REMYND (BE) 2014-05-13 US disclosed
US-20100197703-A1 N-SULFONYL THIAZOLYLPIPERAZINE DERIVATIVES AND RELATED N-SULFONYL HETEROCYCLIC DERIVATIVES FOR THE TREATMENT OF NEURO DEGENERATIVE DISEASES NV REMYND (BE) 2010-08-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100197703-A1 N-SULFONYL THIAZOLYLPIPERAZINE DERIVATIVES AND RELATED N-SULFONYL HETEROCYCLIC DERIVATIVES FOR THE TREATMENT OF NEURO DEGENERATIVE DISEASES SMN1; SMN2, HTT, SNCA CSNK1D 1182/4885LIPE 2030/4885RPA1 4549/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.